Nanomedicine

Nanowerk News (Oct. 15) -- Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. Understanding the interdependency of physiochemical properties of nanomedicines, in correlation to their biological responses and functions, is crucial for their further development of as cancer-fighters. In a recent study, MatSE professor Jianjun Cheng and his collaborators systematically evaluated the size-dependent biological profiles of three monodisperse drug-silica nanoconjugates at 20, 50 and 200 nm. Also: ScienceBlog (Oct. 15), AzoNano (Oct. 16), Medical Xpress (Oct. 16), R&D Magazine (Oct. 16), Controlled Environments Magazine (Oct. 17), News-Medical.net (Oct. 17).